insights_auto
Why is EVGN down 3.09%?
Dive Deeperchevron_right
EVGN:NASDAQ
Evogene Ltd
$0.41
arrow_downward
-3.09%(-0.013) 1D
$0.38
arrow_downward
-6.97% (-0.029)bedtimeAfter hours
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVGN...
Open
$0.43
High
$0.43
Low
$0.39
Mkt. cap
6.55M
Avg. vol.
2.57M
Volume
89.00
52-wk high
$1.50
52-wk low
$0.35
EPS
-$0.90
Beta
1.44
Shares outstanding
15.80M
No. of employees
52
Open
$0.43
High
$0.43
Low
$0.39
Mkt. cap
6.55M
Avg. vol.
2.57M
Volume
89.00
52-wk high
$1.50
52-wk low
$0.35
EPS
-$0.90
Beta
1.44
Shares outstanding
15.80M
No. of employees
52
News stories
From web sources and news partners
Benzinga
·
11 hours ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Stock Titan
·
1 day ago
Holders of about 16.93% sign an Evogene (EVGN) deal that would reshape its board if approved.
TradingView
·
1 day ago
Evogene (EVGN) Reaches Deal With Pure Capital to Reconstitute Board
Profile
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
About Evogene Ltd